Duo Oncology, founded by oncologists, is developing tumor-penetrating nanomedicines to upgraded the foundations of cancer medicine.
Duo’s patented platform prodrug chemistry releases creates nanomedicines that penetrate established tumors to reduce toxicity and improve patient outcomes.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 2730 Sidney St,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.duooncology.com/
- HQ
- Pittsburgh, Pennsylvania
Duo Oncology Questions
Duo Oncology's website is https://www.duooncology.com/
Duo Oncology's LinkedIn profile is https://www.linkedin.com/company/duo-oncology
Duo Oncology has
4 employees.
View email and phone details for 4
employees at Duo Oncology.
Duo Oncology's industry is
Pharmaceutical Manufacturing
Duo Oncology's top competitors are
Western Oncolytics Ltd.,
Lassogen, Inc.,
Bluesphere Bio,
Accession Therapeutics Limited,
Qrono Inc.,
Biovaxys Technology Corp.,
Kalivir Immunotherapeutics,
Singula Bio Ltd.,
Cytoagents, Inc,
Omideon Limited.
Duo Oncology's categories are Pharmaceutical Manufacturing
Duo Oncology's founding year is 2020
